| Literature DB >> 35811879 |
Sanjeev Kumar1,2, Ritika Sharma3, Akanksha Gupta4, Prashant Singh5, Susheel Kalia6, Pankaj Thakur7, Vinod Kumar7.
Abstract
Advances in nanotechnology over the past decade have emerged as a substitute for conventional therapies and have facilitated the development of economically viable biosensors. Next-generation biosensors can play a significant role in curbing the spread of various viruses, including HCoV-2, and controlling morbidity and mortality. Pertaining to the impact of the current pandemic, there is a need for point-of-care biosensor-based testing as a detection method to accelerate the detection process. Integrating biosensors with nanostructures could be a substitute for ultrasensitive label-free biosensors to amplify sensing and miniaturization. Notably, next-generation biosensors could expedite the detection process. An elaborate description of various types of functionalized nanomaterials and their synthetic aspects is presented. The utility of the functionalized nanostructured materials for fabricating nanobiosensors to detect several types of viral infections is described in this review. This review also discusses the choice of appropriate nanomaterials, as well as challenges and opportunities in the field of nanobiosensors.Entities:
Year: 2022 PMID: 35811879 PMCID: PMC9260923 DOI: 10.1021/acsomega.2c01033
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Overview of biosensors representing their ideal characteristics and applications.
Comparative Analysis of Various Types of Biosensors
| biosensors | optical | electrical | mechanical | electrochemical | photoelectrochemical |
|---|---|---|---|---|---|
| principle | optical property changes on sensor’s surface after analyte binding | current or voltage changes on electrode after analyte binding | oscillation at specific resonant frequency that changes by increasing mass on surface | transduce target molecule into digital electrochemical signals | charge-transfer process between photoactive material, an electrode, and an analyte under light illumination |
| analytes | enzymes, antibodies, nucleic acids, aptamers | antibody, affirmer, or aptamer | microbial cell, antibody, nucleic acids | enzymes, antibodies, DNA, aptamers | enzymes, antibodies, DNA, aptamers |
| change detected | optical properties, fluorescence, and absorbance | current or voltage changes on the electrode | resonant frequency of crystal due to change in mass | redox reaction/electrical conductivity as a result of change in ion concentration | charge transfer under light illumination |
| technique used | SPR or LSPR | potentiometric | QCM | amperometric | |
| colorimetric | conductometric | cantilever technology | impedimetric | ||
| FET | |||||
| voltammetric | |||||
| impedance | |||||
| advantages | simple | multiplex label-free detection | high sensitivity | high selectivity and sensitivity over optical biosensors | high sensitivity and lower background signals to analyze the target |
| cost-effective | high specificity and sensitivity | instant response time | lower purchase cost | ||
| rapid detection method without analytical equipment | simple miniaturization process | rapid results | |||
| high throughput | better signal-to-noise ratio | ||||
| limitations | low sensitivity | translation to clinical samples | requires temperature control | low LOD over other biosensors | |
| limited capability of a multiplex | buffered solution may interfere | sensitive to sample matrix effect | inconsistent reproductivity | ||
| no specific binding | |||||
| sensitivity and precision | depends on NMs binding with biosensor | depends on NMs binding with biosensor | depends on NMs binding with biosensor | depends on NMs binding with biosensor | depends on NMs binding with biosensor |
Figure 2Schematic of (A) optical biosensor and (B) FET biosensor for detection.
Figure 3Schematic of (A) QCM and (B) electrochemical biosensor.
Functionalized SWCNT Biosensor for the Detection and/or Conjugation with Biomolecules
| s. no. | materials used for surface modification | synthesis method | application | ref |
|---|---|---|---|---|
| 1 | PEG | RF-CCVD method | drug delivery | ( |
| 2 | PEG | cancer drug delivery and imaging tool | ( | |
| 3 | human serum protein | biological application and binds with siRNA | ( | |
| 4 | CTAB | binding with siRNA oligonucleotides | ( | |
| 5 | HMDA and PDDA | delivery of siRNA | ( | |
| 6 | PL–PEG | delivery of siRNA and gene silencing | ( | |
| 7 | –NH3+ | gene delivery and delivery of plasmid DNA | ( | |
| 8 | –Lys-NH3+ | gene delivery and delivery of plasmid DNA | ( | |
| 9 | biotin | tumor-targeted drug delivery | ( | |
| 10 | DNA | reflux process followed by addition of DNA | determination of daunorubicin anti-cancer drug | ( |
| 11 | mesoporous silicon | facile stain-etching and sonothermal process | detection of non-enzymatic glucose | ( |
Figure 4Schematic of the synthesis of PAMAM-MWCNTs.
Figure 5Schematic of Au NRs to form a Au-Env complex.
Activation of a Au Molecule for Sensing and/or Conjugation with Biomolecules
| s. no. | materials used | synthesis method | application | ref |
|---|---|---|---|---|
| 1 | PDDA | electrostatic layered assembly | DNA vaccine delivery for HIV treatment | ( |
| 2 | PEI | electrostatic layer assembly | DNA vaccine delivery for HIV treatment | ( |
| 3 | pRNA | biosensor for sensing of miRNA | ( | |
| 4 | aptamer | biosensor for sensing of adenosine | ( | |
| 5 | DNA | optimized biosensor for detection of miRNA | ( | |
| 6 | silsesquioxane | layer-by-layer deposition method | label-free DNA biosensor for Zika virus detection | ( |
| 7 | DNA | amplified electrogenerated chemiluminescence, biosensing for the detection of thymine DNA glycosylase | ( | |
| 8 | PEG | chemical reduction method | biosensor for the detection of ssDNA | ( |
| 9 | citrate | citrate reduction method | sensing of hepatitis C RNA virus by colorimetric gene sensor | ( |
| 10 | core–shell Fe3O4–Au NPs/PNA | biosensor for detection of miRNA | ( |
Figure 6Principle of assay for the staining of dsDNA dye for quantification.
Figure 7Schematics of (A) dispersion of modified SiO2 into the PU matrix and (B) synthesis of ssDNA f-SiO2 NPs.
Various Applications of Engineered SiO2 Particles
| s. no. | materials used for surface modification | particle size | synthesis method | application | ref |
|---|---|---|---|---|---|
| 1 | PPG-P | 30 nm | in situ polymerization | uniformly distributed the NPs in polyurethane matrix | ( |
| 2 | APTES | 68 nm | water-in-oil microemulsion method | mechanical strength, thermal stability, and gas permeability | ( |
| 3 | MPTMS | 32 nm | water-in-oil microemulsion method | enhancement in mechanical strength, thermal stability, and gas permeability | ( |
| 4 | PTMS | 34 nm | water-in-oil microemulsion method | enhancement in mechanical strength, thermal stability, and gas permeability | ( |
| 5 | VTES | 38 nm | water-in-oil microemulsion method | enhancement in mechanical strength, thermal stability, and gas permeability | ( |
| 6 | 5′-phosphorylated ssDNA | 120 ± 5 nm | layer-by-layer electrostatic adsorption | capture and detection of single-stranded RNA | ( |
Figure 8Schematic of a modification of BNNTs with carbohydrate.
Modified BNNTs Used in Various Applications
| s. no. | materials used | application | ref |
|---|---|---|---|
| 1 | PLC | biocompatibility, mechanical properties | ( |
| 2 | PEI | biomedical applications | ( |
| 3 | glucose | biomedical applications and interaction with protein | ( |
| 4 | lactose | biomedical applications and interaction with protein | ( |
| 5 | starch | biomedical applications and interaction with protein | ( |
| 6 | glycol–chitosan | biomedical applications | ( |
Figure 9Schematic of the synthesis of Fe3O4/UCNP nanocomposite.
Figure 10Schematic of the synthesis of UCNP@SiO2@Ag nanocomposite.
Activated UCNPs with Application in Sensing and/or Conjugation with Biomolecules
| s. no. | surface modification | materials used | synthesis method | particle size | application | ref |
|---|---|---|---|---|---|---|
| 1 | NaYF4:Yb,Er | streptavidin | DNA sensor | ( | ||
| 2 | NaYF4:Yb,Er@SiO2 | amino group | 30 nm | delivery of siRNA | ( | |
| 3 | NaYF4:Yb,Tm@SiO2 | PEG spacer carrying NHS groups | reverse microemulsion method | 38 nm | protein conjugation | ( |
| 4 | NaYF4:Yb,Er@SiO2 | amino-ethoxy silane | 50 nm | bioimaging and conjugate with biomolecules | ( | |
| 5 | NaYF4:Yb,Er@SiO2 | antibody | glutaraldehyde spacer method | bioimaging and conjugate with biomolecules | ( | |
| 6 | NaYF4:Yb,Er@SiO2 | anti-Cx43 | glutaraldehyde spacer method | bioimaging and conjugate with biomolecules | ( | |
| 7 | NaYF4:Yb,Er | Fe3O4 | 100–150 nm | biolabeling, imaging of cancer cells, and conjugation with biomolecules | ( | |
| 8 | NaYF4:Yb,Er@SiO2@Ag | DNA | reverse microemulsion process | conjugate with DNA and cell imaging | ( |
Figure 11Schematic of the synthesis of biosensors based on PANI/PA polymer hydrogel.
Figure 12Schematic of the synthesis of β-CD-functionalized CdS NRs.
Figure 13Schematic of the detection of microRNA using PEG-activated Ppy NWs.
Modification of Various Particles Used for Sensing and/or Conjugation with Biomolecules
| s. no | surface modification | materials used | particle size | synthesis method | application | ref |
|---|---|---|---|---|---|---|
| 1 | PANI | PA | electrochemical copolymerization | electrochemical detection of miRNA | ( | |
| 2 | CuO NPs | dopamine | 30 nm | microwave-assisted methodology | colorimetric biosensor for detection of cysteine | ( |
| 3 | Gd2O3 NRs | aspartic acid | 14.26 ± 0.13 nm | electrochemical biosensor for detection of vitamin D3 | ( | |
| 4 | CdS NRs | β-CD | 25–40 nm | solvothermal method | PEC biosensor for detection of HIV DNA | ( |
| 5 | PtCo mesoporous nanosphere | DNA | 43.82 nm | electrochemical immunodetection of N6-methyladenosine RNA | ( | |
| 6 | Ppy NW | PEG | 300 nm | electrochemical oxidation | biosensor for detection of miRNA | ( |
| 7 | CuO NPs | streptavidin | lateral flow strip biosensor for the sensing of human papillomavirus (HPV) type 16 DNA | ( | ||
| 8 | dopamine | aggregate induced emission dye (TPE-BTD) | for detecting H2O2, G-quadruplex DNA, glucose, and Dam MTase solid | ( | ||
| 9 | CRISPR/Cas 13a system | catalytic hairpin DNA circuit | detection of multiple RNA | ( | ||
| 10 | CRISPR/Cas 13a | Ti3C2T | detection of nucleic acid using wireless sensor | ( |
Figure 14Schematic of currently used diagnostic techniques and possible biosensing platforms for COVID-19. Reprinted with permission from ref (107). Copyright 2020 Elsevier B.V.